Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty
Status:
Completed
Trial end date:
2020-08-22
Target enrollment:
Participant gender:
Summary
Peripheral nerve blocks for joint and extremity surgeries have long been proven to provide
effective post-operative analgesia. Of these surgeries, total hip arthroplasty (THA) remains
one of the most common orthopedic procedures in the United States with approximately 300,000
operations performed annually. At our institution, post-operative analgesia in these patients
is primarily provided through parenteral and oral opioid medications. Quadratus lumborum
blocks (QLB) have been described and implemented for various surgical procedures including
caesarean and laparoscopic ovarian surgery. Recently, there has been increasing interest in
the efficacy of quadratus lumborum blocks for THA. Currently, case reports have established a
precedent regarding the efficacy of the QLB for THA in providing superior analgesia and
decreasing visual analog pain scores (VAS), but randomized trials are still lacking. The goal
of this study is to compare pain scores (VAS), opioid consumption, physical therapy scores,
and patient and surgeon satisfaction in patients that receive QLB versus no peripheral nerve
blockade in patients undergoing THA. The results of this study have the potential to change
standard of care for patients undergoing THA.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Analgesics, Opioid Anesthetics Anesthetics, Local Bupivacaine Epinephrine Epinephryl borate Racepinephrine